Showing results (21-30 of 407) with videos related to
Sort By:
Pageof 41
Applied Optics|June 26, 2010
Resistance of holograms made in dichromated gelatin emulsion to fission neutron damageJ P Golden, G P Summers, W H CarterCancer Investigation|January 1, 1987
Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatmentG L Wampler, W H Carter, E D CampbellFundamental and Applied Toxicology : Official Journal of the Society of Toxicology|December 1, 1985
Assessing pyridostigmine efficacy by response surface modelingD E Jones, W H Carter, R A CarchmanThe Journal of Family Practice|August 1, 1986
Erythromycin in the treatment of acute bronchitis in a community practiceF X Brickfield, W H Carter, R E JohnsonPediatrics|May 23, 2001
Obstructive nephropathy in children: long-term progression after relief of posterior urethral valveK S Roth, W H Carter, J C ChanCancer Detection and Prevention|December 29, 2000
17 alpha androstenediol inhibition of breast tumor cell proliferation in estrogen receptor-positive and -negative cell linesP N Huynh, W H Carter, R M LoriaBiometrics|September 1, 1980
Survival analysis of drug combinations using a hazards model with time-dependent covariatesD M Stablein, W H Carter, G L WamplerBiometrics|September 1, 1983
Confidence regions for constrained optima in response-surface experimentsD M Stablein, W H Carter, G L WamplerCancer|August 1, 1984
Solid tumor models for the assessment of different treatment modalities. XXII. The alternate utilization of radiotherapy and chemotherapyW B Looney, H A Hopkins, W H CarterJournal of Immunology (Baltimore, Md. : 1950)|December 1, 1983
Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft diseaseR C Hard, W H Carter, P H BickPageof 41